Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Volume Ropivacaine Interscalene Block in Shoulder Surgery
NCT03081728Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Apr 2017
- Primary completion
- Nov 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Incidence of hemidiaphragmatic paralysis at 24 hours. Started Apr 2017; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03081728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081728.